Is it necessary to monitor blood hydroxychloroquine concentrations in patients with systemic lupus erythematosus?

被引：3
|
作者：
Costedoat-Chalumeau, N.
Amoura, Z.
Hulot, J. -S.
Lechat, P.
Piette, J. -C.
机构：
[1] CHU Pitie Salpetriere, APHP, Ctr Reference Natl Pour Lupus & Syndrome Antiphos, Serv Med Interne, F-75651 Paris 13, France
[2] CHU Pitie Salpetriere, Serv Pharmacol, F-75651 Paris 13, France
来源：
REVUE DE MEDECINE INTERNE | 2006年 / 27卷 / 09期
关键词：
Hydroxychloroquine; therapeutic drug monitoring; systemic lupus erythematosus;
D O I：
10.1016/j.revmed.2006.05.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：655 / 657
页数：3
相关论文
共 50 条
  • [21] Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus
    Liu, Lucy H.
    Fevrier, Helene B.
    Goldfien, Robert
    Hemmerling, Anke
    Herrinton, Lisa J.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1309 - 1315
  • [22] Diplopia in a patient under hydroxychloroquine for systemic lupus erythematosus
    Sabbagh, M
    REVUE DU RHUMATISME, 1997, 64 (01): : 65 - 65
  • [23] Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus
    Takeyama, Shuhei
    Kono, Michihito
    Aso, Kuniyuki
    Kamada, Kazuro
    Tada, Maria
    Tarumi, Masato
    Kosumi, Yui
    Yoshimura, Masaru
    Ninagawa, Keita
    Hisada, Ryo
    Fujieda, Yuichiro
    Kato, Masaru
    Amengual, Olga
    Atsumi, Tatsuya
    MODERN RHEUMATOLOGY, 2024, 35 (01) : 110 - 117
  • [24] Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
    Rua-Figueroa, Inigo
    Carlos Salman-Monte, Tarek
    Pego Reigosa, Jose Maria
    Galindo Izquierdo, Maria
    Diez Alvarez, Elvira
    Fernandez-Nebro, Antonio
    Roman Ivorra, Jose Andres
    Calvo Penades, Inmaculada
    Artaraz Beobide, Joseba
    Calvo Alen, Jaime
    REUMATOLOGIA CLINICA, 2024, 20 (06): : 312 - 319
  • [25] Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
    Bajwa, Asima
    Khurana, Gitanjali
    Kimpel, Donald
    Reddy, Ashvini K.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2015, 8 : 121 - 126
  • [26] THE LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN EFFECTS OF HYDROXYCHLOROQUINE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    HODIS, HN
    QUISMORIO, FP
    WICKHAM, E
    BLANKENHORN, DH
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (04) : 661 - 665
  • [27] Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus A case report
    Wang, Gang
    Zhuo, Ning
    Liao, Zheng
    Qi, Wei
    Tian, Feng
    Wen, Zhenhua
    Li, Jingyang
    MEDICINE, 2021, 100 (22) : E25688
  • [28] Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus
    Miyagawa, Ippei
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Iwata, Shigeru
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Kubo, Satoshi
    Inoue, Yoshino
    Ueno, Masanobu
    Tanaka, Yoshiya
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (03) : 434 - 442
  • [29] Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
    Ruiz-Irastorza, Guillermo
    Paredes-Ruiz, Diana
    Arizpe, Fernando
    Campos-Rodriguez, Valerio
    Moreno-Torres, Victor
    Amo, Laura
    Ruiz-Arruza, Ioana
    Martin-Iglesias, Daniel
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [30] Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI)
    Yokogawa, Naoto
    Kato, Yukihiko
    Sugii, Shoji
    Inada, Shinichi
    MODERN RHEUMATOLOGY, 2012, 22 (02) : 249 - 255
12345